tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ken Trbovich, 11 are a BUY (61.11%), 6 are a HOLD (33.33%), 1 are a SELL (5.56%).
Analyst Ken Trbovich, carries an average stock price target met ratio of 62.22% that have a potential upside of 26.28% achieved within 686 days. Previously, Ken Trbovich worked at JANNEY.
Ken Trbovich’s has documented 46 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ASRT, Assertio Therapeutics at 29-Aug-2018.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 6/28/2017. The price target of $22 was fulfilled within 2 days with a profit of $4.95 (18.37%) receiving and performance score of 91.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-May-2026
$21.8
$-1.7 (-7.23%)
$18
2 months 7 days ago
(05-May-2026)
0/9 (0%)
$-0.36 (-1.62%)
Buy Since 07-Nov-2022
$18
$-5.5 (-23.40%)
$3
3 months 3 days ago
(09-Apr-2026)
1/6 (16.67%)
$-0.02 (-0.11%)
612
Buy Since 09-Nov-2021
$2.75
$-20.75 (-88.30%)
$3.5
2 years 1 months 14 days ago
(28-May-2024)
0/3 (0%)
$-12.25 (-81.67%)
Buy Since 18-May-2022
$4
$-14.02 (-77.80%)
2 years 8 months 9 days ago
(03-Nov-2023)
0/2 (0%)
$-31.1 (-88.60%)
Hold Since 22-Feb-2017
$16
$4.22 (35.82%)
$52
6 years 11 months 3 days ago
(08-Aug-2019)
0/4 (0%)
$4.76 (42.35%)
What Year was the first public recommendation made by Ken Trbovich?
